Vincent Milano

Vincent Milano has served as a member of Aclaris’ board of directors since January 2020. Mr. Milano currently serves as the President and Chief Executive Officer, and as a member of the board of directors, of Idera Pharmaceuticals, Inc., a publicly held biopharmaceutical company, since 2014. Prior to joining Idera, between 1996 and 2014, Mr. Milano served in increasingly senior roles at ViroPharma Inc., a pharmaceutical company acquired by Shire plc in 2014, most recently as Chairman, President, and Chief Executive Officer from 2008 to 2014. Prior to joining ViroPharma, Mr. Milano served in increasingly senior roles, most recently as a senior manager, at KPMG LLP, an independent registered public accounting firm, from 1985 to 1996. Within the past five years, Mr. Milano also served on the boards of directors of the publicly held companies ViroPharma, Spark Therapeutics, Inc., and Vanda Pharmaceuticals Inc. Mr. Milano currently serves on the boards of directors of VenatoRx Pharmaceuticals, Inc., a privately held company, and Life Sciences Cares Philadelphia, a non-profit organization. Mr. Milano received a Bachelor of Science in Accounting from Rider College.